MolecularHealth announced today that members of its Innovation and Applied Research team, led by Chief Scientific Officer David Jackson, Ph.D., will speak at this year’s WIN Symposium, titled, “WINning Combinations for Precision Cancer Medicine.” The company will present three poster presentations that demonstrate cancer research findings tied closely to the symposium’s theme of breakthrough biomarker investigations and combined therapeutic approaches.
Help employers find you! Check out all the jobs and post your resume.
